Could Makary Face Facility Issues As US FDA Commissioner?

Footprint in sand
The FDA's real property footprint could shrink under the second Trump Administration. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from US FDA

More from Geography